APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: A retrospective baseline analysis of a national dataset

American Journal of Drug and Alcohol Abuse

Volumn 39, Issue 4, 2013, Pages 219-226

  Kalapatapu, Raj K ^a,b   Delucchi, Kevin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

APOE; Cigarette smoking; Cognitive; E4; Mild cognitive impairment; Neurocognitive

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ARTICLE; DESCRIPTIVE RESEARCH; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; RETROSPECTIVE STUDY; SMOKING;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; COGNITION; DATABASES, FACTUAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84880199930     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2013.800084     Document Type: Article

References (48)

1. Small BJ, Rosnick CB, Fratiglioni L, Backman L. Apolipoprotein E and cognitive performance: A meta-analysis. Psychol Aging 2004; 19:592-600.
2. Crean S, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL, Arrighi HM. Apolipoprotein E epsilon4 prevalence in Alzheimer s disease patients varies across global populations: A systematic literature review and meta-analysis. Dement Geriatr Cogn Disord 2011;31:20-30.
3. Sadigh-Eteghad S, Talebi M, Farhoudi M. Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer s disease. A meta-analysis. Neurosciences (Riyadh ) 2012;17:321-326.
4. Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy. Nat Rev Neurol 2013;9: 106-118.
5. Horejsi B, Ceska R. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis. Physiol Res 2000;49: S63-S69. (Pubitemid 30399353)
6. Ashare RL, Karlawish JH, Wileyto EP, Pinto A, Lerman C. APOE varepsilon4, an Alzheimer s disease susceptibility allele, and smoking cessation. Pharmacogenomics J 2012. doi: 10.1038/tpj.2012.49. [Epub ahead of print].
7. National Alzheimer s Coordinating Center (NACC). Available from: Https://www.alz.washington.edu [last accessed 15 Apr 2013].
8. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, et al. The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006;20:210-216. (Pubitemid 44900933)
9. Uniform Data Set (NACC). Available from: Https://www.alz.washington. edu/WEB/study-pop.html [last accessed 15 Apr 2013].
10. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, et al. The Alzheimer s Disease Centers Uniform Data Set (UDS): The neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009;23:91-101.
11. Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, Hubbard JL, et al. The National Alzheimer s Coordinating Center (NACC) database: The Uniform Data Set. Alzheimer Dis Assoc Disord 2007;21:249-258. (Pubitemid 47367978)
12. Ward RA, Brier ME. Retrospective analyses of large medical databases: What do they tell us? J Am Soc Nephrol 1999;10: 429-432. (Pubitemid 29068084)
13. Shi L, Wu EQ, Hodges M, Yu A, Birnbaum H. Retrospective economic and outcomes analyses using non-US databases: A review. Pharmacoeconomics 2007;25:563-576. (Pubitemid 47048040)
14. Uniform Data Set - Initial Visit Packet (NACC). Available from: Https://www.alz.washington.edu/NONMEMBER/UDS/DOCS/VER2/ivpfillable.pdf [last accessed 15 Apr 2013].
15. Uniform Data Set - Forms and Documentation (NACC). Available from: Https://www.alz.washington.edu/WEB/forms-uds.html [last accessed 15 Apr 2013].
16. Derived Variables (NACC). Available from: Https://www.alz.washington. edu/WEB/dervar.pdf [last accessed 15 Apr 2013].
17. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488. (Pubitemid 10073130)
18. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. In clinical gerontology: A guide to assessment and intervention. New York (NY): Haworth Press; 1986;165-73. (Pubitemid 17221439)
19. Folstein MF, Folstein SE, McHugh PR. Mini-mental state . A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Wechsler D. Wechsler memory scale-revised. San Antonio (TX): Psychological Corporation; 1987.
21. Wechsler D. Manual for the Wechsler Adult Intelligence Scale -Revised. New York (NY): Psychological Corporation; 1981.
22. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test -Experimental edition. Philadelphia (PA): Lea & Febiger; 1983.
23. Description of available data (NACC). Available from: Https://www.alz.washington.edu/WEB/data-descript.html [last accessed 15 Apr 2013].
24. Shirk SD, Mitchell MB, Shaughnessy LW, Sherman JC, Locascio JJ, Weintraub S, Atri A. A web-based normative calculator for the uniform data set (UDS) neuropsychological test battery. Alzheimers Res Ther 2011;3:32.
25. Kirscht JP, Brock BM, Hawthorne VM. Cigarette smoking and changes in smoking among a cohort of Michigan adults, 1980-82. Am J Public Health 1987;77:501-502. (Pubitemid 17044071)
26. Frank PI, Morris JA, Frank TL, Hazell ML, Hirsch S. Trends in smoking habits: A longitudinal population study. Fam Pract 2004; 21:33-38. (Pubitemid 38240336)
27. Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res 2004;6:S363-S369. (Pubitemid 40124775)
28. Sawyer K, Sachs-Ericsson N, Preacher KJ, Blazer DG. Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. Gerontology 2009;55:32-40.
29. Romero LJ, Schuyler M, Kamboh MI, Qualls C, LaRue A, Liang HC, Rhyne R. The APO E4 allele and cognition in New Mexico Hispanic elderly. Ethn Dis 2002;12:235-241. (Pubitemid 34520549)
30. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 1996;58:574-584. (Pubitemid 26062488)
31. Birmpili E, Katsiki N, Malhotra A, Dimopoulou E, Mikhailidis DP, Tsiligiroglou-Fachantidou A. Gender and socio-economic differences in daily smoking and smoking cessation among adult residents in a Greek rural area. Open Cardiovasc Med J 2012;6: 15-21.
32. Johnson JL, Ratner PA, Malchy LA, Okoli CT, Procyshyn RM, Bottorff JL, Groening M, et al. Gender-specific profiles of tobacco use among non-institutionalized people with serious mental illness. BMC Psychiatry 2010;10:101.
33. Iliceto P, Fino E, Pasquariello S, D Angelo Di Paola ME, Enea D. Predictors of success in smoking cessation among Italian adults motivated to quit. J Subst Abuse Treat 2013;44:534-540.
34. Shiffman S, Kassel JD, Paty J, Gnys M, Zettler-Segal M. Smoking typology profiles of chippers and regular smokers. J Subst Abuse 1994;6:21-35.
35. Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE. Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol 2008;75:178-195. (Pubitemid 350235400)
36. Gustavsson J, Mehlig K, Leander K, Strandhagen E, Bjorck L, Thelle DS, Lissner L, et al. Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women. Atherosclerosis 2012;220: 486-492.
37. Kortmann GL, Dobler CJ, Bizarro L, Bau CH. Pharmacogenetics of smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet 2010;153B:17-28.
38. David SP, Johnstone EC, Churchman M, Aveyard P, Murphy MF, Munafo MR. Pharmacogenetics of smoking cessation in general practice: Results from the patch II and patch in practice trials. Nicotine Tob Res 2011;13:157-167.
39. Mwenifumbo JC, Tyndale RF. Molecular genetics of nicotine metabolism. Handb Exp Pharmacol 2009;192:235-259.
40. Wang JC, Kapoor M, Goate AM. The genetics of substance dependence. Annu Rev Genomics Hum Genet 2012;13:241-261.
41. Benowitz NL. Nicotine addiction. N Engl J Med 2010;362: 2295-2303.
42. Lazary J, Dome P, Faludi G. Genetic and pharmacogenomic data on smoking: The bigger sample size, the less reliable phenotypë A critical review. Neuropsychopharmacol Hung 2011;13:7-13.
43. Iwahashi K, Aoki J. A review of smoking behavior and smokers evidence (chemical modification, inducing nicotine metabolism, and individual variations by genotype: Dopaminergic function and personality traits). Drug Chem Toxicol 2009;32:301-306.
44. Al Koudsi N, Tyndale RF. Genetic influences on smoking: A brief review. Ther Drug Monit 2005;27:704-709. (Pubitemid 44391719)
45. Munafo MR, Johnstone EC. Genes and cigarette smoking. Addiction 2008;103:893-904. (Pubitemid 351715215)
46. Li MD. The genetics of nicotine dependence. Curr Psychiatry Rep 2006;8:158-164.
47. Davies GE, Soundy TJ. The genetics of smoking and nicotine addiction. S D Med 2009;Spec No:43-49.
48. Schnoll RA, Johnson TA, Lerman C. Genetics and smoking behavior. Curr Psychiatry Rep 2007;9:349-357. (Pubitemid 47565023)